10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Central Nervous System Cancers
5 articles
Immune Checkpoint Inhibitors in MS Patients: Low Relapse Risk, Promising Outlook
Study shows low relapse risk for MS patients on immune checkpoint inhibitors, suggesting safe use with precautions.
T-DXd Shows Promising Results for HER2+ Breast Cancer with Brain Metastases
Large trial demonstrates T-DXd's efficacy in treating HER2+ breast cancer with brain metastases.
Promising Brain Breakthrough: T-DXd Shows Hope for HER2-Low Breast Cancer with Brain Metastases
T-DXd demonstrates encouraging intracranial activity in HER2-low breast cancer patients with brain metastases.
Hypofractionated vs. Conventional Radiotherapy for Glioblastoma: A Comparative Study
Study compares hypofractionated and conventional radiotherapy with temozolomide for glioblastoma patients
Vincristine Infusion Time Does Not Affect Neuropathy in Pediatric Cancer
Study finds no difference in neuropathy between 1-hour and push injection of vincristine in children with cancer